Acute myocardial infarction biosensor: a review from bottom up

JA Reyes-Retana, LC Duque-Ossa - Current problems in cardiology, 2021 - Elsevier
Acute myocardial infarction (AMI) is a cardiovascular disease that is produced due to a
deficiency of oxygen generating irreversible damage in the heart muscle. In diagnosis …

[HTML][HTML] The atrium in atrial fibrillation–a clinical review on how to manage atrial fibrotic substrates

PS Cunha, S Laranjo, J Heijman… - Frontiers in …, 2022 - frontiersin.org
Atrial fibrillation (AF) is the most common sustained arrhythmia in the population and is
associated with an important clinical and economic burden. Rigorous assessment of the …

From classic to modern prognostic biomarkers in patients with acute myocardial infarction

C Stătescu, L Anghel, BS Tudurachi, A Leonte… - International Journal of …, 2022 - mdpi.com
Despite all the important advances in its diagnosis and treatment, acute myocardial
infarction (AMI) is still one of the most prominent causes of morbidity and mortality …

Insights into the Role of Galectin‐3 as a Diagnostic and Prognostic Biomarker of Atrial Fibrillation

Y Mohtasham Kia, A Cannavo, P Bahiraie… - Disease …, 2023 - Wiley Online Library
Atrial fibrillation (AF) is an irregular atrial activity and the most prevalent type of arrhythmia.
Although AF is easily diagnosed with an electrocardiogram, there is a keen interest in …

Intermittent fasting and changes in galectin-3: a secondary analysis of a randomized controlled trial of disease-free subjects

BD Horne, JL Anderson, HT May, VT Le… - Nutrition, Metabolism …, 2022 - Elsevier
Background and aims Intermittent fasting reduces risk of interrelated cardiometabolic
diseases, including type 2 diabetes and heart failure (HF). Previously, we reported that …

Circulating Galectin‐3 and Aldosterone for Predicting Atrial Fibrillation Recurrence after Radiofrequency Catheter Ablation

Z Ruan, R Gao, F Wang, G Chen, J Zhu… - Cardiovascular …, 2022 - Wiley Online Library
Background. Circulating galectin‐3 (Gal‐3) and aldosterone (ALD) are involved in fibrosis
and inflammation. However, their potential value as predictors of atrial fibrillation (AF) …

Gentianella acuta prevents acute myocardial infarction induced by isoproterenol in rats via inhibition of galectin-3/TLR4/MyD88/NF-кB inflammatory signalling

JH Sun, HX Yang, TT Yao, Y Li, L Ruan, GR Xu… - …, 2021 - Springer
Abstract Gentianella acuta (G. acuta), as a folk medicine, was used to treat heart disease by
the Ewenki people in Inner Mongolia. However, the effect of G. acuta on acute myocardial …

Biomarkers of ageing and cardiac remodeling are associated with atrial fibrillation

AA Kalstad, PL Myhre, K Laake, TB Opstad… - Scandinavian …, 2021 - Taylor & Francis
Objectives. Ageing is one of the strongest risk factors for atrial fibrillation (AF), and additional
risk factors are also closely related to ageing. Remodeling is part of the pathophysiology of …

Circulating plasma galectin-3 predicts new-onset atrial fibrillation in patients after acute myocardial infarction during hospitalization

Q Wang, W Huai, X Ye, Y Pan, X Yang, M Chen… - BMC Cardiovascular …, 2022 - Springer
Background New-onset atrial fibrillation (NOAF) is a common complication in patients with
acute myocardial infarction (AMI) during hospitalization. Galectin-3 (Gal-3) is a novel …

Differential gene expression patterns in ST-elevation Myocardial Infarction and Non-ST-elevation Myocardial Infarction

M Elahimanesh, N Shokri, E Mahdinia… - Scientific Reports, 2024 - nature.com
Abstract The ST-elevation Myocardial Infarction (STEMI) and Non-ST-elevation Myocardial
Infarction (NSTEMI) might occur because of coronary artery stenosis. The gene biomarkers …